| Document Date: 2012-11-01 19:55:07
Open Document File Size: 296,50 KBShare Result on Facebook
Company Novartis Pharmaceuticals Australia Pty Ltd / Sanofi-Aventis Australia Pty Ltd. / Sharp / Merck / AstraZeneca Pty Ltd / Joan Henderson Christopher Harrison Graeme Miller Management / Pfizer Australia / JanssenCilag Pty Ltd / Dohme (Australia) Pty Ltd / Bayer Australia Ltd / GlaxoSmithKline Australia Pty Ltd / CSL Biotherapies Pty Ltd / Abbott Australasia Pty Ltd / / Event Business Partnership / / Facility University of Sydney / / IndustryTerm prevention of chronic obstructive pulmonary disease / / MedicalCondition asthma COPD / obstructive pulmonary disease / COPD / moderate COPD / chronic obstructive pulmonary disease / very severe COPD / diagnosed COPD / pulmonary disease / mild COPD / severe COPD / Percent Chronic / asthma / / OperatingSystem Hurd / / Organization Family Medicine Research Centre / University of Sydney / Human Research Ethics Committee / Department of Health / / Person Christopher Harrison / / Position Family Physician / / ProvinceOrState New South Wales / / Region South Wales / / Technology X-ray / GPS / /
SocialTag |
The respiratory tract Joan Henderson Christopher Harrison Graeme Miller Management of COPD